Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2021-08-18
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$559.8m
reported value
-16.7% vs Q1 2021
153positions
31.3%in top 10
18 new
27 added
49 reduced
43 sold out
vs Q1 2021
Options: 37 call positions ($457.5m notional), 20 put positions ($219.8m notional) – listed below, not included above.
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOGEN INC BIIB | $43.6m7.79% | Added +120.3k |
| CRISPR THERAPEUTICS AG CRSP | $19.4m3.46% | Added +104.6k |
| X4 PHARMACEUTICALS INC COM | $17.7m3.16% | Added +104.3k |
| TRACON PHARMACEUTICALS INC COM NEW | $17.6m3.15% | Unchanged |
| ALECTOR INC ALEC | $14.1m2.51% | Added +417.2k |
| GALAPAGOS NV LKFT | $13.9m2.48% | Unchanged |
| CHIMERIX INC CMRX | $12.6m2.25% | Reduced -21.6k |
| MACROGENICS INC MGNX | $12.3m2.21% | Reduced -40.9k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $12.2m2.18% | Reduced -230.7k |
| XENON PHARMACEUTICALS INC XENE | $11.9m2.13% | Added +30 |
| MILESTONE PHARMACEUTICALS IN MIST | $10.9m1.95% | Added +143.9k |
| SIERRA ONCOLOGY INC COM NEW | $10.6m1.90% | Added +99.8k |
| VAXCYTE INC PCVX | $10.1m1.80% | Reduced -53.0k |
| RELMADA THERAPEUTICS INC RLMD | $9.6m1.72% | Added +10.0k |
| INTRA-CELLULAR THERAPIES INC ITCI | $9.4m1.68% | Reduced -100.1k |
| AUTOLUS THERAPEUTICS PLC AUTL | $9.0m1.61% | Added +100.0k |
| ANNOVIS BIO INC ANVS | $8.9m1.58% | Reduced -89.8k |
| GOSSAMER BIO INC GOSS | $8.5m1.52% | Unchanged |
| CABALETTA BIO INC CABA | $8.1m1.46% | Added +557.7k |
| CULLINAN THERAPEUTICS INC CGEM | $7.6m1.36% | Added +294.6k |
| ODONATE THERAPEUTICS INC COM | $6.9m1.24% | Added +650.0k |
| SCPHARMACEUTICALS INC SCPH | $6.7m1.20% | Reduced -213.7k |
| CLOVIS ONCOLOGY INC CLVS | $6.6m1.17% | Added +450.0k |
| CHEMOCENTRYX INC CCXI | $6.3m1.13% | New |
| OCULAR THERAPEUTIX INC OCUL | $6.0m1.06% | Unchanged |
| PROTARA THERAPEUTICS INC TARA | $5.7m1.02% | Reduced -64.7k |
| VERASTEM INC COM | $5.7m1.01% | Reduced -1.3m |
| VINCERX PHARMA INC COM NEW | $5.5m0.99% | Reduced -11.9k |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $5.5m0.99% | New |
| SHATTUCK LABS INC STTK | $5.5m0.99% | Unchanged |
| HORIZON THERAPEUTICS PUB L HZNP | $5.1m0.92% | Added +54.2k |
| ACADIA PHARMACEUTICALS INC ACAD | $5.1m0.91% | Added +203.9k |
| LYRA THERAPEUTICS INC LYRA | $5.0m0.90% | Reduced -156.0k |
| FINCH THERAPEUTICS GROUP INC COM | $4.6m0.82% | Added +175.0k |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $4.6m0.81% | New |
| SATSUMA PHARMACEUTICALS INC STSA | $4.5m0.81% | Reduced -32.2k |
| OVID THERAPEUTICS INC OVID | $4.4m0.79% | Unchanged |
| CHARDAN HEALTHCR ACQSTN 2 CO UNIT 99/99/9999 | $4.4m0.78% | Unchanged |
| NEXTCURE INC COM | $4.2m0.74% | Added +62.9k |
| I MAB NBP | $3.9m0.69% | Reduced -203.9k |
| ARK ETF TR ARKG | $3.8m0.68% | Added +39.0k |
| RADNET INC RDNT | $3.7m0.67% | New |
| KADMON HLDGS INC KDMN | $3.6m0.65% | Unchanged |
| DBV TECHNOLOGIES S A SPONSORED ADR | $3.6m0.63% | Unchanged |
| AILERON THERAPEUTICS INC ALRN | $3.5m0.63% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $3.4m0.60% | Unchanged |
| TRICIDA INC TCDA | $3.3m0.60% | Unchanged |
| SYNLOGIC INC COM | $3.3m0.59% | Reduced -644.3k |
| AMICUS THERAPEUTICS INC FOLD | $3.3m0.59% | Unchanged |
| COMPASS PATHWAYS PLC CMPS | $3.2m0.58% | Reduced -140.9k |
| PLIANT THERAPEUTICS INC PLRX | $3.2m0.57% | Unchanged |
| VIKING THERAPEUTICS INC VKTX | $3.1m0.56% | Reduced -200.0k |
| BELLUS HEALTH INC NEW BLU | $3.1m0.56% | Added +610.5k |
| INCYTE CORP INCY | $3.1m0.55% | Added +13.5k |
| BIOATLA INC BCAB | $3.0m0.53% | Unchanged |
| SYNAPTOGENIX INC COM NEW | $3.0m0.53% | New |
| CERECOR INC COM | $2.9m0.52% | Unchanged |
| VISTAGEN THERAPEUTICS INC VTGN | $2.9m0.52% | Reduced -2.0m |
| ASCENDIS PHARMA A/S SPONSORED ADR | $2.9m0.51% | Reduced -40.3k |
| AERPIO PHARMACEUTICALS INC COM | $2.8m0.51% | Reduced -975.0k |
| CM LIFE SCIENCES INC COM CL A | $2.8m0.50% | New |
| ELEDON PHARMACEUTICALS INC ELDN | $2.8m0.49% | Added +100.0k |
| GEMINI THERAPEUTICS INC COM | $2.8m0.49% | Reduced -257.9k |
| ALLAKOS INC ALLKG | $2.7m0.48% | Unchanged |
| ALPINE IMMUNE SCIENCES INC NVLS | $2.7m0.48% | Reduced -4.3k |
| HEPION PHARMACEUTICALS INC COM | $2.7m0.48% | New |
| SAVARA INC SVRA | $2.7m0.48% | Reduced -127.6k |
| IMMATICS N.V IMTX | $2.6m0.47% | Reduced -30.0k |
| INMUNE BIO INC INMB | $2.6m0.46% | Reduced -86.7k |
| YUMANITY THERAPEUTICS INC COM | $2.6m0.46% | Unchanged |
| LIQUIDIA CORPORATION LQDA | $2.5m0.45% | Reduced -61.0k |
| CATALYST BIOSCIENCES INC COM NEW | $2.5m0.45% | Unchanged |
| SUTRO BIOPHARMA INC COM | $2.5m0.45% | Unchanged |
| SOLID BIOSCIENCES INC COM | $2.5m0.44% | Added +652.1k |
| CYTOKINETICS INC CYTK | $2.4m0.43% | Reduced -6.1k |
| KALVISTA PHARMACEUTICALS INC KALV | $2.3m0.42% | Reduced -200.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $2.3m0.41% | Unchanged |
| ICAD INC ICAD | $2.2m0.40% | Reduced -89.5k |
| ZOGENIX INC ZGNX | $2.1m0.38% | Unchanged |
| ATRECA INC BCEL | $2.1m0.38% | New |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $2.0m0.36% | Unchanged |
| CYCLERION THERAPEUTICS INC COM | $2.0m0.36% | Added +209.9k |
| INFLARX NV IFRX | $2.0m0.35% | Reduced -33.2k |
| CASI PHARMACEUTICALS INC CASI | $2.0m0.35% | Unchanged |
| QUANTUM SI INC QSI | $2.0m0.35% | New |
| IMMUNOVANT INC IMVT | $2.0m0.35% | New |
| PASSAGE BIO INC COM | $1.9m0.35% | Unchanged |
| VASCULAR BIOGENICS LTD COM | $1.9m0.34% | Unchanged |
| BLACK DIAMOND THERAPEUTICS I BDTX | $1.9m0.34% | Unchanged |
| DIAMEDICA THERAPEUTICS INC DMAC | $1.8m0.33% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $1.8m0.32% | Unchanged |
| MUSTANG BIO INC MBIO | $1.7m0.31% | Unchanged |
| FULCRUM THERAPEUTICS INC FULC | $1.7m0.30% | Reduced -264.0k |
| BELLICUM PHARMACEUTICALS INC BLCM | $1.6m0.29% | Unchanged |
| APPLIED GENETIC TECHNOLOGIES AGTC | $1.6m0.29% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $1.6m0.28% | Reduced -98.4k |
| HARPOON THERAPEUTICS INC COM | $1.6m0.28% | Reduced -155.0k |
| AC IMMUNE SA ACIU | $1.6m0.28% | Added +76.4k |
| ATYR PHARMA INC ATYR | $1.5m0.26% | Unchanged |
| AURIS MEDICAL HOLDING LTD EARS | $1.4m0.26% | Reduced -56.9k |
Sold out since Q1 2021
| Security | Value then |
|---|---|
| CURIS INC | $13.8m1.2m shares |
| PROTHENA CORP PLC PRTA | $11.0m437.4k shares |
| ESSA PHARMA INC EPI | $7.7m264.9k shares |
| SERES THERAPEUTICS INC | $7.2m350.0k shares |
| SAGE THERAPEUTICS INC SAGE | $6.8m91.2k shares |
| ARDELYX INC ARDX | $6.8m1.0m shares |
| LIFESCI ACQUISITION II CORP | $5.2m512.5k shares |
| SCHOLAR ROCK HLDG CORP SRRK | $3.4m67.1k shares |
| BCTG ACQUISITION CORP | $3.3m300.2k shares |
| ACHIEVE LIFE SCIENCES INC ACHV | $3.3m284.2k shares |
| STRONGBRIDGE BIOPHARMA PLC SBBP | $3.2m1.2m shares |
| MORPHIC HLDG INC MORF | $3.2m49.9k shares |
| HIGHCAPE CAP ACQUISITION COR | $3.1m260.0k shares |
| TCR2 THERAPEUTICS INC TCRR | $3.0m136.5k shares |
| NUVATION BIO INC NUVB | $2.6m250.0k shares |
| ALTIMMUNE INC ALT | $2.6m181.9k shares |
| ZAI LAB LTD ZLAB | $2.2m17.0k shares |
| PDS BIOTECHNOLOGY CORP PDSB | $1.7m383.4k shares |
| MILLENDO THERAPEUTICS INC | $1.6m1.3m shares |
| VIRACTA THERAPEUTICS INC SNSS | $1.4m155.6k shares |
| SORRENTO THERAPEUTICS INC SRNE | $1.4m165.9k shares |
| RUBIUS THERAPEUTICS INC RUBY | $1.3m50.0k shares |
| ONCONOVA THERAPEUTICS INC | $1.1m1.1m shares |
| KINIKSA PHARMACEUTICALS LTD | $949.0k51.3k shares |
| SYNDAX PHARMACEUTICALS INC SNDX | $914.0k40.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| BIOGEN INC BIIB · Call | $93.5m270.0k shares | Reduced |
| ALNYLAM PHARMACEUTICALS INC ALNY · Put | $50.9m300.0k shares | New |
| INTELLIA THERAPEUTICS INC NTLA · Call | $47.7m294.4k shares | New |
| ALNYLAM PHARMACEUTICALS INC ALNY · Call | $33.2m195.7k shares | New |
| CRISPR THERAPEUTICS AG CRSP · Put | $32.4m200.0k shares | Added |
| CASSAVA SCIENCES INC FLNA · Call | $31.2m365.0k shares | New |
| REATA PHARMACEUTICALS INC RETA · Put | $24.8m174.9k shares | Added |
| HORIZON THERAPEUTICS PUB L HZNP · Call | $23.4m250.0k shares | Reduced |
| CELLDEX THERAPEUTICS INC NEW CLDX · Call | $20.1m600.0k shares | Added |
| APELLIS PHARMACEUTICALS INC APLS · Put | $19.0m300.0k shares | New |
| APELLIS PHARMACEUTICALS INC APLS · Call | $19.0m300.0k shares | New |
| INCYTE CORP INCY · Call | $16.8m200.0k shares | Unchanged |
| BAUSCH HEALTH COS INC BHC · Call | $16.1m550.0k shares | Reduced |
| ZOGENIX INC ZGNX · Call | $14.7m850.0k shares | Unchanged |
| SAGE THERAPEUTICS INC SAGE · Call | $14.4m254.3k shares | Added |
| SAGE THERAPEUTICS INC SAGE · Put | $14.2m250.0k shares | Unchanged |
| CHEMOCENTRYX INC CCXI · Put | $13.0m967.6k shares | Added |
| SERES THERAPEUTICS INC Call | $11.9m500.0k shares | Reduced |
| RAPT THERAPEUTICS INC Put | $11.1m350.0k shares | New |
| ARK ETF TR ARKG · Put | $11.1m119.9k shares | Reduced |
| ARENA PHARMACEUTICALS INC ARNA · Call | $10.2m150.0k shares | Unchanged |
| OCULAR THERAPEUTIX INC OCUL · Call | $9.9m700.0k shares | Added |
| FATE THERAPEUTICS INC FATE · Put | $8.7m100.0k shares | Reduced |
| INTRA-CELLULAR THERAPIES INC ITCI · Call | $8.6m210.0k shares | Unchanged |
| MACROGENICS INC MGNX · Call | $8.1m300.0k shares | Added |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |